AzTrials
AzTrials

Decreased Fetal Movements, Unspecified Trimester, Other FetusNCT00513942

Effects of Fetal Movement Counting in Third Trimester of Pregnancy

A study testing Fetal Movement Counting in people with Decreased Fetal Movements, Unspecified Trimester, Other Fetus and Worries, run by Norwegian Institute of Public Health at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim is to test effects of using formal kick counting chart in the third trimester of pregnancy in an unselected population. The research questions are: Does Fetal Movement Counting (FMC): 1. Improve the identification of risk pregnancies/pathology? 2. Affect the women's well-being? 3. Read more about this study

Who is it for?
Ages 16 years and older, women only
What is being tested?
Fetal Movement Counting
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,200 participants
Where
1 siteNorway
Study dates
Aug 2007to Sep 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • women booking at screening ultrasound in pregnancy week 17-20
  • native speaking women
  • singleton pregnancies

Who cannot join

  • women with pregnancies with severe anomalies or other cause to consider termination

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Norwegian Institute of Public Health

    Oslo, NO-0403

Other trials in Norway

About this study

Official title: Effects of Fetal Movement Counting - a Randomized Controlled Trial of an Unselected Population

The aim is to test effects of using formal kick counting chart in the third trimester of pregnancy in an unselected population. The research questions are:

Does Fetal Movement Counting (FMC):

  1. Improve the identification of risk pregnancies/pathology?
  2. Affect the women's well-being?
  3. Stimulate maternal-fetal attachment antepartum?
Read the detailed description

Fetal activity serves as an indirect measure of central nervous system integrity and function, and regular FM can be regarded as an expression of fetal well-being.A hypoxic fetus responds automatically by redistributing blood away from the non-essential organs which lead to a reduction of non-vital activities; movements. Conversely, pregnancies in which the mother report decreased fetal movements (DFM) is associated with adverse outcomes and may indicate danger for the fetus. In cases were DFM are associated with complications of pregnancy, maternal lack of sensitivity and awareness to fetal movements may be a risk factor for her pregnancy. The most important current identifier of DFM is the women's perception of what is a decrease of FM. Fetal movement counting may be a tool for the mothers that might increase identification of risk pregnancies.

The outcome measures are (referring to the research questions above):

  1. Identification of risk pregnancies/pathology?
  2. Primary outcome measures: Numbers of identified pathological conditions in pregnancies (fetal growth restriction (FGR), acute caesarean section on fetal indication/non-reactive non-stress test (NST), oligohydramnios, pathologic blood flow in arteria umbilicalis, maternal perception of absent fetal movements for more than 24 hours before admission to hospital, or perinatal death).
  3. Secondary outcome measures: Frequency of consultations because of maternal concern, use of resources in evaluation of these pregnancies (NST, ultrasound, Doppler, recurrent consultations), induced or spontaneous start of delivery, mode of birth.
  4. Affect the women's well-being?
  5. Primary outcome measure: Maternal concern.
  6. Secondary outcome measure: Maternal satisfaction with use of FMC and sense of control in interpretation of signals from own body and child.
  7. Stimulate maternal-fetal attachment antepartum?
  8. Primary outcome measure: Maternal-fetal attachment.
  9. Secondary outcome measure: Health promoting behavior in pregnancy (smoking habits, use of alcohol, attending standard program for antenatal care).
Being tested
Fetal Movement Counting
Keywords
Fetal Movement, Maternal-Fetal-Attachment, Fetus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fetal Movement CountingOther

    Women in the intervention group will receive an information pamphlet. The main items will be basic information and interpretation of fetal activity and instructions when to contact health professionals if experiencing DFM.

Study groups in NCT00513942
Study groupRoleWhat they receive
ANo interventionThese women will follow standard antenatal care according to the Norwegian Guidelines
BActive comparatorIntervention group for Fetal Movement Counting
Receives: Other: Fetal Movement Counting

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Identification of pathological conditions in pregnancies and birth, maternal concern (Cambridge Worry Scale), maternal-fetal attachment (Prenatal Attachment Inventory)

    Measured: One and a half year

Secondary outcomes (1)
  1. Frequency of consultations, use of resources and mode of birth, maternal satisfaction and sense of control in interpretation of signals from own body and child, health promoting behavior

    Measured: One and a half year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2007 (estimated)
  2. Study startAug 2007
  3. Primary completionMay 2010
  4. Study completionSep 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00513942
Sponsor's protocol ID
NIPH-EPAM-335
Status last verified
Oct 2014
First submitted
8 Aug 2007
Last updated
20 Oct 2014
Results posted
No
Data monitoring committee
No

Publications

  • Saastad E, Winje BA, Stray Pedersen B, Froen JF. Fetal movement counting improved identification of fetal growth restriction and perinatal outcomes--a multi-centre, randomized, controlled trial. PLoS One. 2011;6(12):e28482. doi: 10.1371/journal.pone.0028482. Epub 2011 Dec 21.

    PubMed 22205952
  • Winje BA, Saastad E, Gunnes N, Tveit JV, Stray-Pedersen B, Flenady V, Froen JF. Analysis of 'count-to-ten' fetal movement charts: a prospective cohort study. BJOG. 2011 Sep;118(10):1229-38. doi: 10.1111/j.1471-0528.2011.02993.x. Epub 2011 May 18.

    PubMed 21585644

Questions about this trial

What is this clinical trial studying?

A study testing Fetal Movement Counting in people with Decreased Fetal Movements, Unspecified Trimester, Other Fetus and Worries, run by Norwegian Institute of Public Health at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Oct 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Identification of pathological conditions in pregnancies and birth, maternal concern (Cambridge Worry Scale), maternal-fetal attachment (Prenatal Attachment Inventory) (time frame: One and a half year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00513942, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in